Europe Launches 2018 with $3.3 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts

Europe Launches 2018 with $3.3 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts

Europe Launches 2018 with $3.3 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts


Attachment: European Pharma-Biotech Kickoffs 1Q17, European 1Q17 Pharma-Biotech Kickoffs

SUGAR LAND--February 27, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The European Pharmaceutical & Biotech Industry, better described as the Life Science Industry, includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Europe's volume of project activity continues to impress, all the more so, when the reported activity is expanded to include Russia and Turkey in Western Asia.

Within this article: Details of the European Pharma-Biotech Industry

Subscribe Now!(All Fields Required)

Standard Membership - Free